DGAP-Adhoc: Sanochemia Pharmazeutika AG: Board of

Sanochemia Pharmazeutika AG / Change of Personnel

29.05.2009 

Release of a Adhoc News, transmitted by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------

SANOCHEMIA Pharmazeutika AG wishes to supplement its early ad-hoc
announcement with the information that Maria Popova, responsible for
research and development activities at the Company, has already been
responsible for the areas of Business Development, Marketing and Sales as a
co-opted member of the Board of Management since March of this year. In
recent months, Maximilian Hudl has successively withdrawn from involvement
in these areas and was most recently responsible for Supply Chain
Management at Sanochemia Pharmazeutika AG as well as acting as General
Manager of Sanochemia Diagnostics Deutschland.

Maria Popova has been at SANOCHEMIA since late 2007 where she has already
successfully restructured the Company's Research and Development division.
A significantly more focussed strategy is now aimed at increasing the
volume of SANOCHEMIA's operational business. Far-reaching steps to achieve
a rapid implementation of the cost-cutting programs and increase efficiency
are now firmly on track.

Popova aims to combine action plans across the group in order to achieve
further rises in sales revenues, while also securing tangible and
sustainable cost-savings in the current financial year. In particular, the
objective is to speedily intensify the Company's successful export
activities and to cut costs, most specifically in areas such as operational
expenses. Major cost-cutting measures are needed at present in order to
improve SANOCHEMIA's cost structure and to underpin the future prospects of
the Company. By means of taking these steps, SANOCHEMIA also aims to
satisfy the demands of the capital market and generate significant levels
of shareholder value in the coming years.



Margarita Hoch
Investor Relations 
phone: +43 / 1 / 3191456 / 335 
fax:      +43 / 1 / 3191456/ 344 
m.hoch@sanochemia.at 
www.sanochemia.at



DGAP 29.05.2009 
---------------------------------------------------------------------------
 
Language:     English
Issuer:       Sanochemia Pharmazeutika AG
              Boltzmanngasse 9a - 11
              A-1091 Wien
              Österreich
Phone:        +43 (1) 319 14 56-0
Fax:          +43 (1) 319 14 56-44
E-mail:       office@sanochemia.at
Internet:     www.sanochemia.at
ISIN:         AT0000776307
WKN:          919963
Indices:      Prime Standard
Listed:       Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
              in Berlin, Stuttgart, München, Hamburg, Düsseldorf
 
End of News                                     DGAP News-Service
 
---------------------------------------------------------------------------
DGAP-Adhoc: Sanochemia Pharmazeutika AG: Board of Management Change (II)
